CoChat

Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression

Open access
Gualtieri, Alberto, Andreola, Federica, Sciamanna, Ilaria, Sinibaldi-Vallebona, Paola, Serafino, Annalucia, Spadafora, Corrado · 2013 · Oncotarget
Cited by 43

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

// Alberto Gualtieri 1 , Federica Andreola 2 , Ilaria Sciamanna 1 , Paola Sinibaldi-Vallebona 3 , Annalucia Serafino 2 and Corrado Spadafora 1 1 Istituto Superiore di Sanità, Rome, Italy; 2 Institute of Translational Pharmacology, CNR, Rome, Italy; 3 Department of Experimental Medicine and Surgery - University of Rome “Tor Vergata”, Rome, Italy. Correspondence: Corrado Spadafora, email: // Keywords : LINE-1 retrotransposons; SINE retrotransposons; reverse transcriptase; copy number amplification; breast cancer progression Received : July 17, 2013 Accepted : August 7, 2013 Published : August 9, 2013 Abstract In higher eukaryotic genomes, Long Interspersed Nuclear Element 1 (LINE-1) retrotransposons and endogenous retroviruses represent large families of repeated elements encoding reverse transcriptase (RT) proteins. Short Interspersed Nuclear Element B1 (SINE B1) retrotrasposons do not encode RT, but use LINE-1-derived RT for their retrotransposition. We previously showed that many cancer types have an abundant endogenous RT activity. Inhibition of that activity, by either RNA interference-dependent silencing of active LINE-1 elements or by RT inhibitory drugs, reduced proliferation and promoted differentiation in cancer cells, indicating that LINE-1-encoded RT is required for tumor progression. Using MMTV-PyVT transgenic mice as a well-defined model of breast cancer progression, we now report that both LINE-1 and SINE B1 retrotransposons are up-regulated at a very early stage of tumorigenesis; LINE-1-encoded RT product and enzymatic activity were detected in tumor tissues as early as stage 1, preceding the widespread appearance of histological alterations and specific cancer markers, and further increased in later progression stages, while neither was present in non-pathological breast tissues. Importantly, both LINE-1 and SINE B1 retrotransposon families undergo copy number amplification during tumor progression. These findings therefore indicate that RT activity is distinctive of breast cancer cells and that, furthermore, LINE-1 and SINE B1 undergo copy number amplification during cancer progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1188

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 43

Metadata

Authors
Gualtieri, A., Andreola, F., Sciamanna, I., Sinibaldi-Vallebona, P., Serafino, A., & Spadafora, C.
Venue
Oncotarget
Published
2013-08-09
Volume
4
Issue
11
Pages
1882-1893
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2121342526
Cited by
43
References
8
FWCI
7.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression. https://app.cochat.ai/papers/10.18632/oncotarget.1188
The paper
Gualtieri, A., Andreola, F., Sciamanna, I., Sinibaldi-Vallebona, P., Serafino, A., & Spadafora, C. (2013). Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression. Oncotarget. https://doi.org/10.18632/oncotarget.1188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.